Aarti Industries Ltd
Aarti Industries Ltd
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Aarti Industries Ltd insights
49 extracted metrics + investor summaries across FY11–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
6- Stock is trading at 3.21 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.11% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 9.43% of profits over last 3 years
- Debtor days have increased from 50.1 to 61.8 days.
Growth Rate
AI Analysis — Bull vs Bear
Aarti Industries trades at a market cap of ₹18,973 Cr with a PE of 36.7x and a 3-year ROE of just 7%. The company has shown a sharp TTM profit recovery of 122% and TTM sales growth of 27%, but longer-term profit compounding remains negative at -9% over 3 years and -5% over 5 years.
- TTM profit growth of 122% signals a strong cyclical recovery in earnings after a multi-year downturn
- TTM sales growth of 27% indicates improving demand and pricing environment for specialty chemicals
- 10-year compounded sales growth of 11% demonstrates consistent long-term revenue scaling ability
- Stock CAGR of 43% over the last 1 year reflects renewed market confidence in the business turnaround
- 10-year stock CAGR of 15% shows the company has delivered meaningful long-term wealth creation
- 5-year compounded sales growth of 13% is healthy and ahead of many chemical peers
- 10-year ROE averaging 14% suggests the business has historically been capable of generating superior returns on equity
- 3-year compounded profit growth is -9%, indicating earnings destruction over the medium term despite revenue growth
- 3-year ROE of only 7% is well below cost of equity and reflects poor capital efficiency in recent years
- PE of 36.7x is elevated relative to the 7% ROE, suggesting the stock is priced for a recovery that must materialize
- Price-to-book of 3.28x is high given the subdued return ratios, limiting margin of safety
- Debtor days have increased from 50.1 to 61.8 days, signalling deteriorating working capital discipline
- Dividend payout of only 9.43% of profits over 3 years offers negligible income to shareholders
- 5-year compounded profit growth of -5% shows earnings have not kept pace even with 13% sales CAGR, pointing to margin pressure
- Potential interest cost capitalization, if confirmed, would mean reported profits overstate true economic earnings
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 profit surges 227% YoY Jul 30
Standalone net profit jumped 227% YoY to ₹144 crore in Q1FY27, while consolidated PAT rose 260% to ₹155 crore, driven by higher revenue and improved margins.
- New China subsidiary approved Jul 30
Board approved incorporation of a wholly owned subsidiary in China on July 30, 2026, citing strategic expansion into the market.
- Suyog Kotecha appointed as MD Jul 30
CEO Suyog Kotecha will become Managing Director effective October 1, 2026, while three Gogri promoter directors transition to Non-Executive roles, signaling professional management.
- Investor meetings in Asia planned Aug 6
Company officials will attend investor meetings in Singapore and Hong Kong from August 11-14, 2026, engaging with Nuvama and Avendus analysts.
- Q1FY27 earnings call uploaded Jul 31
Audio recording of Q1FY27 earnings conference call held on July 31, 2026 has been uploaded to the company website per SEBI LODR requirements.
- Promoter stake reclassified to public Jul 30
Board approved moving Ratanben Premji Gogri from Promoter Group to Public category, affecting a 0.38% stake. Exchange approval is pending.
- Q1 FY27 earnings call scheduled Jul 21
Conference call to discuss Q1 FY27 results was scheduled for July 31, 2026, featuring management commentary and Q&A session.
TL;DR: Aarti Industries delivered a standout Q1FY27 with 227% YoY profit growth and improving margins, signaling strong operational recovery. Strategic moves include a China subsidiary and transition to professional management under a new MD from October 2026. No visible headwinds in recent news flow. The trend is clearly improving, and execution on the China expansion and margin sustainability will be key monitorables going forward.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,414 | 1,454 | 1,732 | 1,773 | 1,851 | 1,628 | 1,843 | 1,949 | 1,675 | 2,100 | 2,318 | 2,205 | 2,387 |
| Expenses | 1,214 | 1,221 | 1,473 | 1,489 | 1,546 | 1,431 | 1,612 | 1,687 | 1,463 | 1,809 | 1,997 | 1,864 | 2,005 |
| Operating Profit | 200 | 233 | 259 | 284 | 305 | 197 | 231 | 262 | 212 | 291 | 321 | 341 | 382 |
| OPM % | 14% | 16% | 15% | 16% | 16% | 12% | 13% | 13% | 13% | 14% | 14% | 15% | 16% |
| Other Income | 0 | 0 | 8 | -1 | 6 | 7 | 5 | 3 | 4 | 22 | -13 | 1 | 5 |
| Interest | 40 | 58 | 54 | 59 | 64 | 62 | 85 | 64 | 60 | 100 | 69 | 112 | 83 |
| Depreciation | 89 | 93 | 97 | 98 | 102 | 108 | 111 | 113 | 114 | 120 | 121 | 119 | 124 |
| PBT | 71 | 82 | 116 | 126 | 145 | 34 | 40 | 88 | 42 | 93 | 118 | 111 | 180 |
| Tax % | 1% | -11% | -7% | -5% | 6% | -53% | -15% | -9% | -2% | -14% | -13% | -23% | 14% |
| Net Profit | 70 | 91 | 124 | 132 | 137 | 52 | 46 | 96 | 43 | 106 | 133 | 137 | 155 |
| EPS in Rs | 1.93 | 2.51 | 3.42 | 3.64 | 3.78 | 1.43 | 1.27 | 2.65 | 1.19 | 2.92 | 3.67 | 3.78 | 4.27 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,890 | 3,006 | 3,163 | 3,806 | 4,168 | 4,186 | 4,506 | 6,086 | 6,619 | 6,371 | 7,271 | 8,286 | 9,010 |
| Expenses | 2,424 | 2,434 | 2,509 | 3,106 | 3,202 | 3,209 | 3,525 | 4,365 | 5,530 | 5,393 | 6,271 | 7,119 | 7,675 |
| Operating Profit | 466 | 572 | 654 | 700 | 965 | 977 | 982 | 1,720 | 1,089 | 978 | 1,000 | 1,167 | 1,335 |
| OPM % | 16% | 19% | 21% | 18% | 23% | 23% | 22% | 28% | 16% | 15% | 14% | 14% | 15% |
| Other Income | 9 | 6 | 2 | 7 | 2 | 9 | 1 | 1 | 1 | 7 | 16 | 12 | 15 |
| Interest | 138 | 117 | 117 | 132 | 183 | 125 | 86 | 102 | 168 | 211 | 275 | 340 | 364 |
| Depreciation | 82 | 98 | 123 | 146 | 163 | 185 | 231 | 246 | 310 | 378 | 434 | 474 | 484 |
| PBT | 255 | 363 | 416 | 429 | 622 | 676 | 665 | 1,372 | 611 | 395 | 307 | 365 | 502 |
| Tax % | 24% | 26% | 21% | 19% | 19% | 19% | 19% | 14% | 11% | -5% | -8% | -15% | — |
| Net Profit | 208 | 268 | 328 | 346 | 504 | 547 | 535 | 1,186 | 545 | 416 | 331 | 419 | 531 |
| EPS in Rs | 5.81 | 7.71 | 9.62 | 10.24 | 14.18 | 15.39 | 15.02 | 32.71 | 15.04 | 11.49 | 9.13 | 11.56 | 14.64 |
| Div. Payout % | 24% | 28% | 3% | 2% | 19% | 11% | 10% | 11% | 17% | 9% | 11% | 9% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 | 181 | 181 |
| Reserves | 972 | 1,096 | 1,321 | 1,538 | 2,587 | 2,892 | 3,416 | 4,335 | 4,739 | 5,109 | 5,424 | 5,774 |
| Borrowings | 1,202 | 1,292 | 1,564 | 2,083 | 2,401 | 2,098 | 2,857 | 2,587 | 2,907 | 3,623 | 3,848 | 4,966 |
| Other Liabilities | 719 | 538 | 573 | 730 | 826 | 1,256 | 1,282 | 748 | 754 | 1,203 | 1,661 | 2,378 |
| Total Liabilities | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
| Fixed Assets | 967 | 1,246 | 1,697 | 1,998 | 2,147 | 2,468 | 3,593 | 3,595 | 4,861 | 5,649 | 6,377 | 6,556 |
| CWIP | 193 | 313 | 270 | 436 | 795 | 1,418 | 1,298 | 1,346 | 1,096 | 1,229 | 1,454 | 2,030 |
| Investments | 139 | 41 | 47 | 47 | 33 | 37 | 64 | 28 | 17 | 23 | 48 | 132 |
| Other Assets | 1,639 | 1,366 | 1,486 | 1,910 | 2,884 | 2,409 | 2,688 | 2,882 | 2,607 | 3,214 | 3,235 | 4,581 |
| Total Assets | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 340 | 574 | 470 | 335 | 736 | 1,102 | 873 | 519 | 1,319 | 1,210 | 1,242 | 775 |
| Investing | -298 | -452 | -529 | -610 | -797 | -1,124 | -1,322 | -1,169 | -1,330 | -1,369 | -1,398 | -1,141 |
| Financing | -23 | -128 | 58 | 279 | 833 | -535 | 614 | 412 | 38 | 420 | -73 | 745 |
| Net Cash Flow | 19 | -7 | 0 | 4 | 772 | -557 | 165 | -239 | 27 | 261 | -229 | 379 |
| Free Cash Flow | 45 | 124 | -60 | -279 | -55 | -23 | -442 | -646 | -8 | -96 | -137 | -346 |
| CFO/OP | 85 | 117 | 87 | 62 | 90 | 130 | 99 | 44 | 129 | 132 | 123 | 67 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 64 | 61 | 63 | 68 | 66 | 64 | 65 | 52 | 49 | 39 | 62 |
| Inventory Days | 123 | 108 | 136 | 144 | 152 | 174 | 190 | 143 | 115 | 121 | 126 | 118 |
| Days Payable | 55 | 67 | 71 | 69 | 55 | 72 | 117 | 53 | 24 | 76 | 107 | 126 |
| Cash Conversion Cycle | 123 | 105 | 125 | 138 | 165 | 168 | 137 | 155 | 143 | 94 | 58 | 54 |
| Working Capital Days | 10 | 10 | -4 | 6 | -14 | -14 | -36 | 22 | -29 | -36 | -44 | -64 |
| ROCE % | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% | 7% | 6% | 7% |
Documents
Frequently Asked Questions about Aarti Industries Ltd
What does Aarti Industries Ltd do?
Where is Aarti Industries Ltd (AARTIIND) listed?
Which sector does Aarti Industries Ltd belong to?
What is the market capitalisation of Aarti Industries Ltd?
What is the PE ratio of Aarti Industries Ltd?
What is the 52-week high and low of Aarti Industries Ltd?
Does Aarti Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Aarti Industries Ltd?
How can I research Aarti Industries Ltd on Tapetide?
Company Information
Aarti Industries Ltd, the flagship company of the Aarti group, manufacturing organic and inorganic chemicals at its major facilities in Vapi, Jhagadia, Dahej and Kutch, in Gujarat and in Tarapur in Maharashtra. The company has a strong market position in the NCB-based specialty chemicals segment.[1]